SAPONARO, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 4.106
EU - Europa 3.132
AS - Asia 1.431
SA - Sud America 300
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 44
OC - Oceania 4
Totale 9.076
Nazione #
US - Stati Uniti d'America 3.984
FI - Finlandia 1.929
SG - Singapore 430
CN - Cina 404
IT - Italia 305
DE - Germania 255
BR - Brasile 241
VN - Vietnam 204
PL - Polonia 162
HK - Hong Kong 112
TR - Turchia 101
GB - Regno Unito 95
UA - Ucraina 88
SE - Svezia 84
CA - Canada 69
RU - Federazione Russa 69
FR - Francia 48
IN - India 40
BD - Bangladesh 28
AR - Argentina 22
JP - Giappone 22
BE - Belgio 21
ZA - Sudafrica 21
MX - Messico 19
ID - Indonesia 18
NL - Olanda 18
IQ - Iraq 16
ES - Italia 15
EC - Ecuador 11
CO - Colombia 10
AT - Austria 9
IL - Israele 9
CZ - Repubblica Ceca 7
SC - Seychelles 7
NI - Nicaragua 6
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
UY - Uruguay 5
AU - Australia 4
CL - Cile 4
KR - Corea 4
PR - Porto Rico 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
HU - Ungheria 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
SV - El Salvador 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
PH - Filippine 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
BB - Barbados 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GL - Groenlandia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
Totale 9.020
Città #
Helsinki 1.884
Dallas 763
Ashburn 435
Singapore 289
Fairfield 279
Woodbridge 268
San Jose 172
Warsaw 160
Houston 140
Ann Arbor 135
Beijing 134
Santa Clara 120
Wilmington 119
Chandler 112
Hong Kong 107
Jacksonville 103
Seattle 102
Cambridge 91
Council Bluffs 87
Ferrara 86
Munich 69
Los Angeles 65
New York 62
Ho Chi Minh City 48
Hanoi 47
Izmir 38
Shanghai 33
Nanjing 32
Milan 29
Dong Ket 28
Boardman 24
Princeton 24
São Paulo 24
Turku 23
Brussels 21
Lauterbourg 21
Orem 21
Tokyo 20
Montreal 19
Phoenix 19
Rome 18
San Diego 17
Toronto 16
Washington 15
Buffalo 14
Amsterdam 12
Denver 12
Shenyang 12
Chicago 11
Frankfurt am Main 11
Atlanta 10
Baghdad 10
London 10
Stockholm 10
Brasília 9
Changsha 9
Brooklyn 8
Da Nang 8
Hebei 8
Jiaxing 8
Mexico City 8
Mumbai 8
Redwood City 8
Tianjin 8
Addison 7
Ankara 7
Bremen 7
Guangzhou 7
Haiphong 7
Johannesburg 7
Mcallen 7
Nanchang 7
Naples 7
Poplar 7
Des Moines 6
Hefei 6
Hải Dương 6
Jakarta 6
Managua 6
Montréal 6
North Bergen 6
Palermo 6
Auburn Hills 5
Bari 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Cagliari 5
Chennai 5
Curitiba 5
Falls Church 5
Montevideo 5
Moscow 5
Newark 5
Querétaro 5
San Mateo 5
Tashkent 5
Thái Nguyên 5
Zhengzhou 5
Boston 4
Totale 6.720
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.156
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists 435
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 333
A3 adenosine receptor antagonists: History and future perspectives 322
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 312
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 300
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 285
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 278
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 270
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 252
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 248
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 240
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 233
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 222
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 177
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 172
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy 171
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 159
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 157
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 155
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 152
null 124
null 121
null 118
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 114
null 107
null 103
Transient receptor potential ankyrin 1 (TRPA1) antagonists 97
null 96
null 84
null 83
Totale 9.076
Categoria #
all - tutte 26.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.190
Totale 27.985


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022238 0 0 0 0 28 18 15 15 22 33 23 84
2022/2023286 29 37 4 39 37 40 22 16 37 1 12 12
2023/2024216 17 16 8 5 22 42 6 33 2 6 5 54
2024/2025773 23 42 63 39 72 77 53 47 95 46 109 107
2025/20264.528 211 261 708 256 304 154 208 101 2.016 195 90 24
2026/2027781 143 106 220 268 44 0 0 0 0 0 0 0
Totale 9.076